Evolution of myeloid-mediated immunotherapy resistance in prostate cancerAram Lyu, Lawrence Fong, Laura Valderrábano et al.|Nature|2024Cited by 138
Sequential JAK inhibition enhances antitumor immunity after combined anti–PD-1 and anti-CTLA4Marcel Arias-Badia, Lawrence Fong, Peixi Chen et al.|JCI Insight|2025Cited by 4
548 Evolution of myeloid-mediated mechanisms of immunotherapy resistance at single-cell resolution with human prostate cancer progressionAram Lyu, Lawrence Fong, Zenghua Fan et al.|Regular and Young Investigator Award Abstracts|2023Cited by 1
Abstract 6857: Evolution of myeloid-mediated mechanisms of immunotherapy resistance at single-cell resolution with prostate cancer progressionAram Lyu, Lawrence Fong, Zenghua Fan et al.|Cancer Research|2024Cited by 0
560 Identification and therapeutic target of myeloid-mediated mechanisms of immunotherapy resistance in prostate cancerAram Lyu, Lawrence Fong, Zenghua Fan et al.|Regular and Young Investigator Award Abstracts|2024Cited by 0